Series A - Insilico Medicine
Investment Firm
Overview
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
Announced Date
Feb 27, 2017
Funding Type
Series A
Highlights
Location
Asia
Social
Investor Lead
N/A
Participant Investors
1
| Investor Name |
|---|
 A-Level Capital |
Round Details and Background
Insilico Medicine raised $2800000 on 2017-02-27 in Series A
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
Company Funding History
11
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jul 18, 2017 |  Series A - Insilico Medicine | - | 4.0M | |
| Feb 27, 2017 | Series A - Insilico Medicine | 2 | - | 2.8M |
| Nov 16, 2014 | Convertible Note - Insilico Medicine | 1 | - | 1.2M |
| Apr 16, 2014 | Seed Round - Insilico Medicine | 1 | - | 300.0K |
Recent Activity
There is no recent news or activity for this profile.